July 24, 2016 2:43 PM ET

Pharmaceuticals

Company Overview of Oncalis AG

Company Overview

Oncalis AG engages in the discovery and development of small molecule inhibitors for oncology indications. The company was founded in 2006 and is based in Schlieren, Switzerland. Oncalis AG was a prior subsidiary of ESBATech AG.

Wagistr. 21

Schlieren,  8952

Switzerland

Founded in 2006

Phone:

41 44 733 49 00

Key Executives for Oncalis AG

Chief Executive Officer and Vice Chairman
Chief Financial Officer
Vice President of Drug Development
Compensation as of Fiscal Year 2016.

Similar Private Companies By Industry

Company Name Region
Acino International AG Europe
Albea Pharmaceuticals AG Europe
Alpen Pharma AG Europe
Alpex Pharma SA Europe
Anergis SA Europe

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Oncalis AG, please visit www.oncalis.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.